KIRIN PHARMA
DEAD

Serial Number

77062473

Owner

KIRIN KABUSHIKI KAISHA

Attorney

SUSAN UPTON DOUGLASS

First Use Date

Jul 1, 2007

Filing Date

Dec 12, 2006

Add to watchlist:

No watchlists yet
View on USPTO

KIRIN PHARMA Trademark

Serial Number: 77062473 • Registration: 3474565

KIRIN PHARMA is a trademark filed by KIRIN KABUSHIKI KAISHA on December 12, 2006. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

KIRIN KABUSHIKI KAISHA (37 trademarks)

10-2, NAKANO 4-CHOME
NAKANO-KU, TOKYO , JP

Entity Type: 03

KIRIN HOLDINGS KABUSHIKI KAISHA A/T/A KIRIN HOLDINGS CO., LTD. (16 trademarks)

10-1, SHINKAWA 2-CHOME, CHUO-KU
TOKYO , JP

Entity Type: 03

Kirin Beer Kabushiki Kaisha a/t/a Kirin Brewery Co., Ltd. (2 trademarks)

10-1, Shinkawa 2-Chome
Chuo-Ku, Tokyo , JP

Entity Type: 03

Trademark Details

Filing Date

December 12, 2006

Registration Date

July 29, 2008

First Use Anywhere

July 1, 2007

First Use in Commerce

July 1, 2007

Published for Opposition

May 13, 2008

Cancellation Date

March 6, 2015

Goods & Services

(Based on 44e) pharmaceutical preparations for the treatment of anemia, leukopenia, thrombocytopenia, hyperphosphatemia, hyperparathyroidism, cancer, leukemia, influenza, HIV, myelodysplastic syndrome, infectious diseases, autoimmune diseases; pharmaceutical preparations for mobilization of peripheral blood progenitor cells; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; diagnostic agents, preparations and substances for medical and veterinary use; pre-filled syringes filled with pharmaceutical preparations for the treatment of anemia, leucopenia, thrombocytopenia, mobilization of peripheral blood progenitor cell, hyperphosphatemia, hyperparathyroidism, cancer, leukemia, influenza, HIV, myelodysplastic syndrome, infectious diseases and autoimmune diseases, and for conditioning treatment prior to hematopoietic stem cell transplantation

(Based on 44e) biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical reagents for non-medical and non-veterinary purposes

(Based on 44e) syringes for medical purposes; injection devices for pharmaceuticals; injection needles; blood transfusion apparatus or devices; infusion apparatus or devices for therapeutic purposes

(Based on Use in Commerce) patent licensing; development of new technology for others in the field of human antibodies and biotechnology; medical research

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 6, 2015 C8..
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 13, 2013 ASGN
REGISTERED-PRINCIPAL REGISTER
Jul 29, 2008 R.PR
PUBLISHED FOR OPPOSITION
May 13, 2008 PUBO
NOTICE OF PUBLICATION
Apr 23, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 9, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2008 CNSA
USE AMENDMENT ACCEPTED
Apr 8, 2008 IUAA
EXAMINER'S AMENDMENT ENTERED
Apr 8, 2008 XAEC
AMENDMENT TO USE PROCESSING COMPLETE
Apr 8, 2008 AUPC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 3, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 3, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 3, 2008 CNEA
AMENDMENT FROM APPLICANT ENTERED
Apr 2, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2008 CRFA
ASSIGNED TO LIE
Apr 2, 2008 ALIE
USE AMENDMENT FILED
Mar 27, 2008 IUAF
PAPER RECEIVED
Mar 27, 2008 MAIL
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 28, 2007 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 9, 2007 GNRN
NON-FINAL ACTION E-MAILED
Oct 9, 2007 GNRT
NON-FINAL ACTION WRITTEN
Oct 9, 2007 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2007 TROA
NON-FINAL ACTION E-MAILED
Apr 6, 2007 GNRT
NON-FINAL ACTION WRITTEN
Apr 6, 2007 CNRT
ASSIGNED TO EXAMINER
Apr 5, 2007 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Dec 19, 2006 MDSC
NEW APPLICATION ENTERED
Dec 18, 2006 NWAP